This is a StreetInsider.com Premium Only Page

(FSTX) – FDA

Nov 7, 2022 07:31 AM F-Star Therapeutics (FSTX) Reports Publication of Phase 1 Dose-Escalation Trial of FS118

Jul 20, 2022 08:05 AM F-Star Therapeutics (FSTX) Enters License Agreement with Takeda for a Novel Next-Generation Immuno-oncology Bispecific Antibody

Jun 23, 2022 07:31 AM

Sep 16, 2021 08:06 AM

Jan 4, 2021 08:03 AM

Dec 3, 2020 08:05 AM